Validation of Rome V for irritable bowel syndrome. Ng DYL, Biesiekierski J, Hebbard G, Talley NJ, et al. Lancet Gastroenterol Hepatol 2026;11:953-954.

Read + Share

Amedeo Smart

Independent Medical Education

Ng DYL, Biesiekierski J, Hebbard G, Talley NJ, et al. Validation of Rome V for irritable bowel syndrome. Lancet Gastroenterol Hepatol 2026;11:953-954.
PMID: 42843366